9th Annual Biomarkers Congress
Latest Research at Life Science Meetings
Insights for Personalized Medicine from the Gut Microbiome Dusko Ehrlich Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Functional Proteomics, Companion Diagnostics and Precise Medicine Peter Parker Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Genomics Medicine Raju Kucherlapati Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
The Future of Academic Research towards Translation for Personalized Medicine Charles L Sawyers Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Integrating Companion Diagnostics in the Healthcare — the Insurance Sector Perspective Michael Kolodziej Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Promoting Personalized Medicine through Policy Strategies Christopher P. Austin Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Towards Biomarker-based Personalized Healthcare: Current Status and Future Trends Mikael Dolsten Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Advances in Blood Pressure Genomics Mark J. Caulfield Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Cardiovascular Disease — Implications for Personalized Medicine Julie A. Johnson Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
mTOR Signaling: a Central Pathway to the Pathogenesis of Multiple Inflammatory and Immune System Disorders — Implications for Personalized Medicine Andras Perl Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Stratified Medicine in Autoimmune Diseases: Rheumatoid Arthritis Examples Iain McInnes Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Industry Spotlight — Development of Kalydeco as a Genotype Specific Drug for the Treatment of Cystic Fibrosis Federico Goodsaid Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Industry Spotlight — Development of Selzentry (Maraviroc) and the Companion Diagnostic HIV Tropism Assay Charles Knirsch Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Case Study: Xalkori Companion Diagnostic Hakan Sakul Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Identification of Biomarkers for the Diagnosis, Prediction, and Progression of Alzheimer's Disease Michelle Mielke Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Innovation in Metabolomics to Improve Personalized Healthcare Massimo Loda Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
The Impact of Epigenetics on the Future of Personalized Medicine Jane Mellor Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
Sequencing Approaches for Personalized Cancer Therapy Selection Daniela Starcevic Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
Ways to Making Personalized Medicine more Affordable Naomi Aronson Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
The European Union Regulatory Framework for Companion Diagnostics and Personalized Medicines in Comparison to US Legislation Angela Brand Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.